User:Jeremy S. Myers: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
*[[Special:Emailuser/Jeremy S. Myers|Email me through OpenWetWare]] | *[[Special:Emailuser/Jeremy S. Myers|Email me through OpenWetWare]] | ||
for more information visit: http://www.advancedtargetedproteomics.com | |||
==Education== | ==Education== | ||
Revision as of 08:32, 18 July 2008
Contact Info
- Jeremy S. Myers, Ph.D.
- AstraZeneca Fellow
- Advanced Targeted Proteomics Team Leader
- Vanderbilt University School of Medicine
- Mass Spectrometry Research Center
- Nashville, TN, U.S.A.
- Email me through OpenWetWare
for more information visit: http://www.advancedtargetedproteomics.com
Education
- 2003-2007 Postdoctoral Fellow
- 2003, Ph.D., Louisiana State University
- 1999, B.S., Bucknell University
Research interests
- Targeted Mass Spectrometry-based Proteomic
- Targeted Therapeutics
Publications (since 2007)
- Myers JS, Zhao R, Xu X, Ham AJ, Cortez D. Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage. Cancer Res. 2007 Jul 15;67(14):6685-90. PMID: 17638878
